Log in

688399 Jiangsu Bioperfectus Technologies Co. Ltd. SSE · China

Jiangsu Bioperfectus Technologies Co. (688399) news

Jiangsu Bioperfectus Technologies Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688399, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Jiangsu Bioperfectus Technologies Co. news

We have not published a story on Jiangsu Bioperfectus Technologies Co. yet. When there is news, it will appear here.

Questions about Jiangsu Bioperfectus Technologies Co.

What is the ticker symbol of Jiangsu Bioperfectus Technologies Co.?

Jiangsu Bioperfectus Technologies Co. Ltd. trades under the ticker 688399 on SSE.

Where is Jiangsu Bioperfectus Technologies Co. listed?

Jiangsu Bioperfectus Technologies Co. Ltd. is listed on SSE.

Which country or territory is Jiangsu Bioperfectus Technologies Co. listed under?

Our directory records Jiangsu Bioperfectus Technologies Co. Ltd. under China.

What does Jiangsu Bioperfectus Technologies Co. do?

Our directory classifies Jiangsu Bioperfectus Technologies Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Jiangsu Bioperfectus Technologies Co.?

The ISIN recorded for Jiangsu Bioperfectus Technologies Co. Ltd. is CNE1000055B2.

Does aibio.space cover Jiangsu Bioperfectus Technologies Co.?

aibio.space lists Jiangsu Bioperfectus Technologies Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Jiangsu Bioperfectus Technologies Co.?

Companies in our directory listed in the same country and business area as Jiangsu Bioperfectus Technologies Co.: Hinova Pharmaceuticals, Genfleet Therapeutics (Shanghai), Jiangsu Aidea Pharmaceutical Group Co., Lifecome Biochemistry Co., Beijing Biostar Pharmaceuticals Co., Zhangzhou Pientzehuang Pharmaceutical Co..

Investor discussion: Jiangsu Bioperfectus Technologies Co.

Members talk about Jiangsu Bioperfectus Technologies Co. (688399). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688399 on TradingView.

Listing details

Jiangsu Bioperfectus Technologies Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688399, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Jiangsu Bioperfectus Technologies Co. Ltd.
Ticker
688399
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE1000055B2
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.